Published in Neurological Diseases and Disorders Weekly, March 23rd, 2000
Venlafaxine, nefazodone, mirtazapine, and reboxetine may be superior to traditional tricyclics and the monoamine oxidase inhibitors because they are safer and have fewer side-effects. Their pharmacological action means that they will not interact with other drug treatments; they can also be given to match patients' psychiatric profiles. For example, depressed patients with prominent symptoms of anxiety and/or agitation may benefit from treatment with nefazodone or mirtazapine; neurovegetative symptoms such as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Neurological Diseases and Disorders Weekly